文献速递母胎医学产科

产前诊断中单核苷酸多态性微阵列检测到的杂合性缺失

Absence of heterozygosity detected by single-nucleotide polymorphism array in prenatal diagnosis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-07

合并超声异常的AOH胎儿不良围产结局率(62.5%)显著高于无超声异常者(15.0%)(P<0.001)。建议对AOH胎儿进行系列超声、父母验证、全外显子组测序等综合管理。

要点

  • 产前SNP array检测中AOH发生率为0.97%,可涉及任何染色体。
  • AOH合并超声异常时不良围产结局风险显著升高(62.5% vs 15.0%)。
  • 无创产前检测提示拷贝数异常时需用SNP array确认是否为AOH。

核心结论

  • 产前诊断中AOH并非罕见,其临床意义需结合超声表现综合评估。
  • AOH合并超声异常者不良围产结局风险显著高于无超声异常者。

研究设计与样本

  • 所有胎儿均采用Affymetrix CytoScan HD SNP array平台检测。
  • AOH定义为拷贝数中性的染色体纯合片段。

主要发现

  • AOH见于所有染色体,X、2和16号染色体最常见。
  • AOH长度从部分染色体(9.002-80.222 Mb)至整条染色体不等。
  • 55例AOH胎儿合并超声异常,最常见为多发异常(14/55,25.5%)、泌尿生殖系统畸形(8/55,14.5%)、骨骼畸形(5/55,9.1%)和小于胎龄儿(5/55,9.1%)。
  • 合并超声异常的AOH胎儿不良围产结局率(30/48,62.5%)高于无超声异常者(6/40,15.0%)(P < 0.001)。

临床怎么用

  • 产前SNP array检出AOH后应结合超声表现进行遗传咨询。
  • 建议对AOH胎儿行系列超声检查、父母验证、全外显子组测序、胎盘研究及有效随访。
  • 无创产前检测提示拷贝数异常时,需通过羊水SNP array确认是否为AOH。

局限性

  • 单中心回顾性研究,样本来自单一胎儿医学中心。
  • AOH的临床意义评估仍需更多前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the general occurrence and clinical significance of absence of heterozygosity (AOH), detected by single-nucleotide polymorphism (SNP) array on prenatal diagnosis. METHODS: We recruited pregnancies undergoing invasive prenatal diagnosis at our fetal medicine center over a 6-year period. All fetuses underwent SNP array using the Affymetrix CytoScan HD array platform. AOH was defined as a chromosomal homozygosity segment with neutral copy number. Cases with AOH over 10 Mb in size or with suspected pathogenicity were further analyzed, and the clinical features and outcome were reviewed. RESULTS: Of 10 294 recruited fetuses, 100 (0.97%) with AOH were identified; in 81 (81.0%) of these, AOH occurred in a single chromosome, while 19 (19.0%) patients had multiple AOHs in different chromosomes. AOH was observed in all chromosomes, chromosomes X, 2 and 16 being the most frequently involved. The length of AOH ranged from partial chromosome (9.002-80.222 Mb) to the entire chromosome. Similar AOH regions displayed varied clinical manifestations. In total, 55 patients presented with concomitant ultrasound abnormalities, the most common being multiple abnormalities (14/55 (25.5%)), genitourinary malformations (8/55 (14.5%)), skeletal malformations (5/55 (9.1%)) and small-for-gestational age (5/55 (9.1%)). Notably, the rate of adverse perinatal outcome (including termination of pregnancy, neonatal death, fetal death, selective reduction and miscarriage) in fetuses with AOH and ultrasound abnormalities (30/48 (62.5%)) was higher than in those without ultrasound abnormalities (6/40 (15.0%)) (P < 0.001). Further non-invasive prenatal testing using cell-free fetal DNA from maternal blood indicated chromosomal copy number abnormalities in 11 patients; however, they were confirmed as AOH by SNP array of the amniotic fluid. CONCLUSIONS: Genetic counseling regarding a prenatal diagnosis of AOH remains challenging. To evaluate comprehensively its significance, we propose a management strategy involving further serial ultrasound examinations, parental verification, whole-exome sequencing, placental study and effective follow-up. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Liu J, He Z, Lin S, et al. Absence of heterozygosity detected by single-nucleotide polymorphism array in prenatal diagnosis. Ultrasound Obstet Gynecol. 2021. PMID: 31840905. doi:10.1002/uog.21951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。